Trial Details
Not RecruitingBasic Information
| Clinical ID | c5635 |
|---|---|
| Identifier | NL-OMON47464 |
| Trial Title | A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis - M14-033 |
| Trial URL | Visit Original Page |
Study Information
| Study Results | Yes |
|---|---|
| Conditions | inflammatory bowel disease (IBD) Ulcerative colitis;10018027 |
| Interventions | Investigational Products: AdalimumabMode of administration: Subcutaneous injection (SC)Induction Study: Double-Blind Induction: Subjects will be randomized to receive one of 2 double-blind adalimumab induction dosing regimens.Do |
Participant Information
| Sponsor | AbbVie Deutschland GmbH & Co. KG |
|---|---|
| City | NULL |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | ADULT, ELDER, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |